The Case of the Frozen Addict
(Nova, 2/18/86, copyright PBS)
- drug-induced Parkinsonism
- synthetic heroin ("designer drugs") - at this time, small changes in the chemical structure of an illegal substance could make it a "street-legal" drug (this loophole in the law has since been plugged)
- treated with l-dopa (the standard treatment for Parkinson's disease)
- replaces missing dopamine in the brain (l-dopa is the precursor for dopamine)
- without dopamine, thoughts of movement cannot be translated into the movements themselves
- contaminants in the synthetic drug (produced through sloppy basement chemistry) had destroyed the dopamine neurons in the substantia nigra, producing an advanced Parkinsonian state overnight
- MPPP (synthetic heroin)
- injected rats freeze up
- but only temporarily
- MPTP (the contaminant)
- injected rats are unaffected
- injected monkeys develop Parkinsonism
- revitalized research into Parkinson's disease
- Parkinson's disease
- a disease of old age characterized by:
- fine tremor, especially noticeable in the hands when at rest
- cogwheel rigidity
- difficulty initiating voluntary movements
- masked face
- shuffling gait
- l-dopa therapy
- oftentimes must be taken every few hours, even during the night
- side effects - writhing movements (athetosis) and hallucinations; sometimes schizophreniform psychosis
- severe cases (drug-induced) have been misdiagnosed as hysterical paralysis and as catatonic schizophrenia
- causes: environmental toxins are suspected
- substantia nigra cells die off gradually with aging
- if exposure to a toxin kills off large numbers of the cells, then subsequent cell death with aging results in Parkinson's disease
- 80% of nigral dopamine neurons must die before symptoms become evident
- possible toxins
- MPTP is converted to MPP+ (Cyperquat) in the brain by MAO
- this product is related to chemical herbicides (Cyperquat, Paraquat)
- incidence of Parkinson's disease is highest in agricultural areas and areas with pulp and paper mills (according to a Canadian study cited in the video--a subsequent study done in the midwestern US has found the same pattern, but this study was not mentioned in the video)
- MPTP-like substances (pyridines) are widespread in the environment
- the MAO-blocking drug pargyline prevents the MPTP-induced Parkinsonism and prevents cell death in the substantia nigra
- PET scanning can detect those at risk for Parkinson's disease--someday it may be possible to do a routine brain scan on middle-aged people; those with abnormally low nigral cell counts may then be put on MAO blockers to prevent further nigral cell deterioration
- some new findings since this video was made
- MPTP has become a major research tool in the study of Parkinsonism in animal models
- a Parkinsonian-like state has now been produced in rats
- some research suggests that the toxin binds to a pigment molecule in the substantia nigra called neuromelanin (it is neuromelanin that gives the substantia nigra its dark appearance in primates; rats have very little pigmentation in the substantia nigra, which may be why they are less susceptible to the toxin)
Return to PSYC 415 main page